Net sales totaled $16.2 million in Q2 2025, Net sales increased 23% in the second quarter. This marks the third straight quarter of year-over-year revenue growth. OEM Net Sales-- OEM segment net sales ...

Strong margin expansion driven by new revenue streams, enhanced channel mix, and disciplined cost management Perfect Moment Ltd.

Special 250th anniversary designs offer a golden opportunity to grow the hobby and inspire the next generation of ...

USEG READ THE FULL USEG RESEARCH REPORT 2nd Quarter 2025 Financial and Operating Results On August 12, 2025, U.S. Energy (NASDAQ:USEG) reported 2nd quarter 2025 financial and operating results. The ...

Q2 2025 Management View James V. Caruso, President and CEO, stated that Cellectar has made "significant strides across our ...

Allogene Therapeutics' Q2 2025 update highlights a streamlined ALPHA3 trial, promising ALLO-316 data, and financial discipline.

Condor Energies Inc. ('Condor” or the 'Company”) (TSX:CDR), a Canadian based, internationally focused energy transition company focused on Central Asia is pleased to announce the release of its ...

Clinical trial timelines for key lymphoma and autoimmune disease programs were delayed by approximately two quarters. Cash and investments totaled $302.6 million at the end of Q2 2025, expected to ...

Pivotal Phase 2 ALPHA3 Trial with Cemacabtagene Ansegedleucel (Cema-Cel) in First Line (1L) Consolidation in Large B-Cell ...

Rubin, its next-generation graphics processing unit, might face a delay in its production ramp at TSMC (TSM) due to a ...

Crown Crafts, Inc. (NASDAQ-CM: CRWS) (the "Company") today reported results for the first quarter fiscal year 2026, which ended June 29, 2025. First ...